FDA To Issue Five Guidances On Adaptive Clinical Trial Design
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency will issue a total of five guidance documents regarding adaptive clinical trials, the first of which will examine using multiple endpoints in the same trial.
You may also be interested in...
Slow Down The Adaptive Trials Train, FDA Says
More definitions are needed to ensure that adaptive clinical trials are "not a fad but an innovation," agency tells PhRMA-sponsored workshop.
Slow Down The Adaptive Trials Train, FDA Says
More definitions are needed to ensure that adaptive clinical trials are "not a fad but an innovation," agency tells PhRMA-sponsored workshop.
Adaptive Clinical Trials Should Still Be Designed “Conservatively,” Integra Consultant Says
Assuming a study will need to be large could lead to cost-savings if stopped early, while starting with a small design could result in problems if expansion is needed.